Advanced Medical Solutions Group plc (FRA:AQA)
Germany · Delayed Price · Currency is EUR | Market Cap | 549.53M |
| Revenue (ttm) | 257.01M |
| Net Income (ttm) | 10.64M |
| Shares Out | n/a |
| EPS (ttm) | 0.05 |
| PE Ratio | 51.63 |
| Forward PE | 16.71 |
| Dividend | 0.03 (1.24%) |
| Ex-Dividend Date | Sep 25, 2025 |
| Volume | n/a |
| Average Volume | 1,047 |
| Open | 2.520 |
| Previous Close | 2.540 |
| Day's Range | 2.520 - 2.520 |
| 52-Week Range | 2.040 - 2.780 |
| Beta | n/a |
| RSI | 56.27 |
| Earnings Date | Dec 16, 2025 |
About FRA:AQA
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and Acti... [Read more]
Financial Performance
In 2024, FRA:AQA's revenue was 177.52 million, an increase of 40.66% compared to the previous year's 126.21 million. Earnings were 7.09 million, a decrease of -55.35%.
Financial numbers in GBP Financial StatementsNews
Bridgepoint weighs £550m bid for London-listed medical group AMS
The private equity backer of Burger King UK is weighing a takeover bid for Advanced Medical Solutions Group, a London-listed producer of surgical products.